Target

Anne Philippi et al.
Mutations and variants of ONECUT1 in diabetes
Nature Medicine 2021, vol. 27, issue 11
doi: 10.1038/s41591-021-01502-7

Tao Wang et al.
ATAD2 controls chromatin-bound HIRA turnover
Life Science Alliance 2021, vol. 4, issue 12
doi: 10.26508/lsa.202101151

Amanda Bortolini Silveira et al.
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer
npj Breast Cancer 2021, vol. 7, issue 1
doi: 10.1038/s41523-021-00319-4

Amanda Bortolini Silveira et al.
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer
npj Breast Cancer 2021, vol. 7, issue 1
doi: 10.1038/s41523-021-00319-4

Ivan Bièche et al.
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
Journal of Hematology & Oncology 2021, vol. 14, issue 1
doi: 10.1186/s13045-021-01158-3

Nikaïa Smith et al.
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection
Nature Immunology 2021, vol. 22, issue 11
doi: 10.1038/s41590-021-01028-7

Géraldine Rios et al.
Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing
The Lancet Regional Health - Europe 2021, vol. 10
doi: 10.1016/j.lanepe.2021.100202

Irene Jiménez et al.
Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis
European Journal of Cancer 2021, vol. 154
doi: 10.1016/j.ejca.2021.05.039

Angela Bellini et al.
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Journal of Clinical Oncology 2021, vol. 39, issue 30
doi: 10.1200/jco.21.00086

Angela Bellini et al.
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Journal of Clinical Oncology 2021, vol. 39, issue 30
doi: 10.1200/jco.21.00086